测序专利之争又起!PacBio VS 牛津纳米孔

2017-03-23 佚名 生物探索

牛津纳米孔公司的专利诉讼案总是一个接着一个。在结束了与Illumina公司的专利案之后,牛津纳米孔又接到了PacBio公司的专利诉讼。PacBio声称牛津纳米孔的MinIon和PromethIon设备侵犯了其专利US No.9546400。


牛津纳米孔公司的专利诉讼案总是一个接着一个。去年年初,Illumina公司在一份声明中称牛津纳米孔的MinIon和 PromethIon设备侵犯了自己的专利。到了去年中旬,Illumina公司和牛津纳米孔的官司在庭外和解,牛津纳米孔同意不再出口或售卖包含氨基酸序列纳米孔的产品,并销毁目前库存的产品。

就在上周,牛津纳米孔又被起诉侵犯专利,这次的原告方为PacBio(太平洋生物科学公司)。PacBio在美国特拉华地方法院提出了此项诉讼,声称牛津纳米孔的MinIon和PromethIon设备侵犯了其专利US No.9546400。

PacBio声称,不仅是牛津纳米孔侵犯了该专利,在生产和销售过程中还导致用户也侵犯了该专利。此外PacBio还表示,牛津纳米孔的专利侵犯对PacBio的业务和财产带来了损害,他们要求牛津纳米孔永远停止侵权行为,并赔偿所带来的损失、诉讼费以及律师费。

对于此项诉讼,牛津纳米孔的首席执行官Gordon Sanghera发表声明,向客户保证他们的服务不会发生变化。Gordon Sanghera 说,“我们相信这是竞争对手引发的一场无聊诉讼,我向所有的客户保证,这次诉讼以及其他诉讼不会破坏到我们的商业行为。”

牛津纳米孔的MinIon是一款手持纳米孔测序商业设备,PromethIon是通量更高、能够满足即时需求的测序仪。MinION也是牛津纳米孔家公司的核心产品,市场价为1000美元/个,主要用于病原监测、宏基因组学、变异检测,基因测序。

其实在去年8月份,PacBio就曾对牛津纳米孔提起过诉讼,指控其侵犯了专利US No. 9404146——核酸测序的组合物和方法。这项专利于去年8月份发行,包括使用双核苷酸模板来提高精度的单分子测序方法。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1978285, encodeId=f9b319e828557, content=<a href='/topic/show?id=fcbbe73746f' target=_blank style='color:#2F92EE;'>#纳米孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77374, encryptionId=fcbbe73746f, topicName=纳米孔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 17 12:18:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200789, encodeId=6aec200e8948, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun May 21 10:09:38 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917401, encodeId=e8d7191e40104, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Sep 15 18:18:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182144, encodeId=d81e1821449b, content=看看了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Mar 23 10:02:43 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-12-17 axin009
  2. [GetPortalCommentsPageByObjectIdResponse(id=1978285, encodeId=f9b319e828557, content=<a href='/topic/show?id=fcbbe73746f' target=_blank style='color:#2F92EE;'>#纳米孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77374, encryptionId=fcbbe73746f, topicName=纳米孔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 17 12:18:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200789, encodeId=6aec200e8948, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun May 21 10:09:38 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917401, encodeId=e8d7191e40104, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Sep 15 18:18:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182144, encodeId=d81e1821449b, content=看看了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Mar 23 10:02:43 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-05-21 189****7206

    学习了谢谢分享。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1978285, encodeId=f9b319e828557, content=<a href='/topic/show?id=fcbbe73746f' target=_blank style='color:#2F92EE;'>#纳米孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77374, encryptionId=fcbbe73746f, topicName=纳米孔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 17 12:18:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200789, encodeId=6aec200e8948, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun May 21 10:09:38 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917401, encodeId=e8d7191e40104, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Sep 15 18:18:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182144, encodeId=d81e1821449b, content=看看了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Mar 23 10:02:43 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-09-15 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1978285, encodeId=f9b319e828557, content=<a href='/topic/show?id=fcbbe73746f' target=_blank style='color:#2F92EE;'>#纳米孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77374, encryptionId=fcbbe73746f, topicName=纳米孔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sun Dec 17 12:18:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200789, encodeId=6aec200e8948, content=学习了谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5Kzuf9u71gZhPYMiajRtENwicoAABeQtfXOlic8ibhYSy6DvJZWUDVtjRvTfqBffr1XJ6JLtFB5kHicthl/0, createdBy=08bb2061153, createdName=189****7206, createdTime=Sun May 21 10:09:38 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917401, encodeId=e8d7191e40104, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Sep 15 18:18:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182144, encodeId=d81e1821449b, content=看看了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Mar 23 10:02:43 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-03-23 xiaotaiyang1

    看看了解一下

    0

相关资讯

逾期未答复 韩春雨基因编辑专利被视为撤回

据国家知识产权局网站消息,近日以河北科技大学副教授韩春雨、浙江大学基础医学院研究员沈啸为发明人的专利——以Argonaute核酸酶为核心的基因编辑技术,因申请人未在规定期限内答复国家知识产权的第一次审查意见通知书,该专利的申请被视为撤回。2017年1月9日,国家知识产权局发布该专利申请的“视为撤回通知书”。

葛均波院士团队又一专利成功转化

2016年9月20日,复旦大学附属中山医院对外宣布:近日,该院心内科葛均波院士团队申报的国家发明专利“一种瓣膜夹合器”,以180万元入门费+2%销售提成的价格,独占许可给苏州拓宇医疗科技有限公司。这是继今年3月“一种经外周动脉途径植入的主动脉瓣环系统”成功转让给杭州启明医疗器械有限公司以来,葛均波院士团队成功转化的第二项微创介入瓣膜治疗的发明专利。二尖瓣反流是最常见的心脏瓣膜疾病。严重二尖瓣反流会

2017,这10大重磅药物专利悬了!(礼来、吉利德、辉瑞、诺华……)

专利对于药物而言,相当于生命周期的结点。药物专利一旦到期,企业依靠专利保护获得的销售额和利润会一落千丈,很多昔日业绩显赫的明星药物因为专利危机而惨淡退场。2017年,又有哪些重磅药物将遭遇专利悬崖呢?近日,FiercePharma推出“Top 10 U.S. patent losses of 2017”,列举了10款即将在2017年面临专利过期的药物,它们分别来自于礼来、辉瑞、吉利德、诺华……

大型药企畅销药遭遇专利悬崖困境

对医药巨头来说,专利药物就是他们手上的现金牛。然而,倘若专利到期,其遭遇到的困境和市场激烈竞争是他们不得不面对的。

骨折,绝非老年人的专利!

骨折是一种严重影响人民身体健康和生活质量的常见疾病,它不仅可导致患者出现疼痛和活动能力受限,而且可并发肺部感染、泌尿系感染和压疮等疾病,给患者及其家庭带来沉重负担。在大多数人的印象里,骨折是老年人的“专利”;但其实,中年人(特别是中年女性)也容易发生骨折,也应该积极预防。 近1/5中年女性发生骨折近期,我们调查了800例老年人中年期(45~59岁)的骨折情况,发现中年男性骨折发生率为7.

韩春雨回应专利申请被视为撤回:换了方式递交

近日,有媒体报道称,以河北科技大学副教授韩春雨、浙江大学基础医学院研究员沈啸为发明人的专利——以Argonaute核酸酶为核心的基因编辑技术,因申请人未在规定期限内答复国家知识产权局的第一次审查意见通知书,该专利的申请被视为撤回。2017年1月9日,国家知识产权局发布该专利申请的“视为撤回通知书”。

· 2017-01-13

-->